These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 15035103
1. [Regulatory mechanism of osteoclast differentiation and function]. Okumura S, Udagawa N, Takahashi N. Nihon Rinsho; 2004 Feb; 62 Suppl 2():90-6. PubMed ID: 15035103 [No Abstract] [Full Text] [Related]
3. [Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. Udagawa N, Takahashi N. Nihon Rinsho; 2002 Mar; 60 Suppl 3():672-8. PubMed ID: 11979968 [No Abstract] [Full Text] [Related]
7. [Recent advances in research of bone resorption]. Inoue D. Nihon Rinsho; 2002 Mar; 60 Suppl 3():48-56. PubMed ID: 11979946 [No Abstract] [Full Text] [Related]
8. [Crosstalk between the immune and skeletal system]. Takayanagi H. Ryumachi; 2003 Oct; 43(4):624-31. PubMed ID: 14598653 [No Abstract] [Full Text] [Related]
10. [Recent advances in the regulation of bone remodeling]. Matsumoto T. Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093 [No Abstract] [Full Text] [Related]
11. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. Glass DA, Karsenty G. Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912 [Abstract] [Full Text] [Related]
12. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects]. Ueland T, Bollerslev J, Mosekilde L. Ugeskr Laeger; 2002 Jul 01; 164(27):3526-30. PubMed ID: 12116680 [Abstract] [Full Text] [Related]
13. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. Zaidi M, Blair HC, Moonga BS, Abe E, Huang CL. J Bone Miner Res; 2003 Apr 01; 18(4):599-609. PubMed ID: 12674320 [Abstract] [Full Text] [Related]
15. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Takahashi N, Udagawa N, Suda T. Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918 [Abstract] [Full Text] [Related]
16. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Aubin JE, Bonnelye E. Medscape Womens Health; 2000 Mar 24; 5(2):5. PubMed ID: 10792853 [Abstract] [Full Text] [Related]
17. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. Biochem Biophys Res Commun; 1998 May 08; 246(1):199-204. PubMed ID: 9600092 [Abstract] [Full Text] [Related]
18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug 08; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
19. [Recent progress of bone cell culture system (review)]. Koshihara Y. Nihon Rinsho; 2002 Mar 08; 60 Suppl 3():79-87. PubMed ID: 11979973 [No Abstract] [Full Text] [Related]
20. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. Ishida M, Amano S. J Bone Miner Metab; 2004 Mar 08; 22(5):415-29. PubMed ID: 15316862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]